Differential regulation of TNF receptors in maternal leukocytes is associated with severe preterm preeclampsia

References

• American College of Obstetricians and Gynecologists (ACOG). ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol 2002;33:159–67
   Google Scholar
• Arulkumaran N, Lightstone L. Severe pre-eclampsia and hypertensive crises. Best Practice Res Clin Obstetr Gynaecol 2013;27:877–84
   PubMed Web of Science ®Google Scholar
• Staff AC, Dechend R, Redman CW. Review: preeclampsia, acute atherosis of the spiral arteries and future cardiovascular disease: Two new hypotheses. Placenta 2013;34:S73–8
   Google Scholar
• Redman CW, Sargent IL. Placental stress and pre-eclampsia: a revised view. Placenta 2009;30:S38–42
   PubMed Web of Science ®Google Scholar
• Haider S, Knofler M. Human tumour necrosis factor: physiological and pathological roles in placenta and endometrium. Placenta 2009;30:111–23
   PubMed Web of Science ®Google Scholar
• Chen HL, Yang YP, Hu XL, et al. Tumor necrosis factor alpha mRNA and protein are present in human placental and uterine cells at early and late stages of gestation. Am J Pathol 1991;139:327–35
   PubMed Web of Science ®Google Scholar
• Peracoli JC, Rudge MV, Peracoli MT. Tumor necrosis factor-alpha in gestation and puerperium of women with gestational hypertension and pre-eclampsia. Am J Reprod Immunol 2007;57:177–85
   PubMed Web of Science ®Google Scholar
• Alexander BT, Cockrell KL, Massey MB, et al. Tumor necrosis factor-alpha-induced hypertension in pregnant rats results in decreased renal neuronal nitric oxide synthase expression. Am J Hypertens 2002;15:170–5
   PubMed Web of Science ®Google Scholar
• LaMarca BB, Cockrell K, Sullivan E, et al. Role of endothelin in mediating tumor necrosis factor-induced hypertension in pregnant rats. Hypertension 2005;46:82–6
   PubMed Web of Science ®Google Scholar
• LaMarca B, Speed J, Fournier L, et al. Hypertension in response to chronic reductions in uterine perfusion in pregnant rats: effect of tumor necrosis factor-alpha blockade. Hypertension 2008;52:1161–7
   PubMed Web of Science ®Google Scholar
• Cabal-Hierro L, Lazo PS. Signal transduction by tumor necrosis factor receptors. Cell Signal 2012;24:1297–305
   PubMed Web of Science ®Google Scholar
• Bemelmans MH, Gouma DJ, Buurman WA. Influence of nephrectomy on tumor necrosis factor clearance in a murine model. J Immunol 1993;150:2007–17
   PubMed Web of Science ®Google Scholar
• Lok CA, Jebbink J, Nieuwland R, et al. Leukocyte activation and circulating leukocyte-derived microparticles in preeclampsia. Am J Reprod Immunol 2009;61:346–59
   PubMed Web of Science ®Google Scholar
• Hao S, Zhao H, Darzynkiewicz Z, et al. Expression and function of NFAT5 in medullary thick ascending limb (mTAL) cells. Am J Physiol Renal Physiol 2009;296:F1494–503
   PubMedGoogle Scholar
• Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29:2002–7
   Web of Science ®Google Scholar
• Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008;3:1101–8
   PubMed Web of Science ®Google Scholar
• Irani RA, Zhang Y, Zhou CC, et al. Autoantibody-mediated angiotensin receptor activation contributes to preeclampsia through tumor necrosis factor-alpha signaling. Hypertension 2010;55:1246–53
   PubMed Web of Science ®Google Scholar
• Zhou CC, Irani RA, Zhang Y, et al. Angiotensin receptor agonistic autoantibody-mediated tumor necrosis factor-alpha induction contributes to increased soluble endoglin production in preeclampsia. Circulation 2010;121:436–44
   PubMed Web of Science ®Google Scholar
• Cindrova-Davies T, Sanders DA, Burton GJ, Charnock-Jones DS. Soluble FLT1 sensitizes endothelial cells to inflammatory cytokines by antagonizing VEGF receptor-mediated signalling. Cardiovasc Res 2011;89:671–9
   PubMed Web of Science ®Google Scholar
• Zhou CC, Irani RA, Dai Y, et al. Autoantibody-mediated IL-6-dependent endothelin-1 elevation underlies pathogenesis in a mouse model of preeclampsia. J Immunol 2011;186:6024–34
   PubMed Web of Science ®Google Scholar
• Beckmann I, Efraim SB, Vervoort M, et al. Tumor necrosis factor-alpha in whole blood cultures of preeclamptic patients and healthy pregnant and nonpregnant women. Hypertens Pregnancy 2004;23:319–29
   PubMed Web of Science ®Google Scholar
• Mosimann B, Wagner M, Birdir C, et al. Maternal serum tumour necrosis factor receptor 1 (TNF-R1) at 30–33 weeks in the prediction of preeclampsia. J Matern Fetal Neonatal Med 2013;26:763–7
   PubMed Web of Science ®Google Scholar
• Terrado J, Monnier D, Perrelet D, et al. Soluble TNF receptors partially protect injured motoneurons in the postnatal CNS. Eur J Neurosci 2000;12:3443–7
   PubMedGoogle Scholar
• McDermott MF, Aksentijevich I, Galon J, et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 1999;97:133–44
   PubMed Web of Science ®Google Scholar
• Aderka D, Wysenbeek A, Engelmann H, et al. Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus. Arthritis Rheum 1993;36:1111–20
   PubMedGoogle Scholar
• Cope AP, Aderka D, Doherty M, et al. Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases. Arthritis Rheum 1992;35:1160–9
   PubMed Web of Science ®Google Scholar
• Cereda C, Baiocchi C, Bongioanni P, et al. TNF and sTNFR1/2 plasma levels in ALS patients. J Neuroimmunol 2008;194:123–31
   PubMed Web of Science ®Google Scholar
• Opsjon SL, Novick D, Wathen NC, et al. Soluble tumor necrosis factor receptors and soluble interleukin-6 receptor in fetal and maternal sera, coelomic and amniotic fluids in normal and pre-eclamptic pregnancies. J Reprod Immunol 1995;29:119–34
   PubMed Web of Science ®Google Scholar
• Shahid M, Francis J, Majid DS. Tumor necrosis factor-alpha induces renal vasoconstriction as well as natriuresis in mice. Am J Physiol Renal Physiol 2008;295:F1836–44
   PubMedGoogle Scholar
• Muller DN, Shagdarsuren E, Park JK, et al. Immunosuppressive treatment protects against angiotensin II-induced renal damage. Am J Pathol 2002;161:1679–93
   PubMed Web of Science ®Google Scholar
• Elmarakby AA, Quigley JE, Pollock DM, Imig JD. Tumor necrosis factor alpha blockade increases renal Cyp2c23 expression and slows the progression of renal damage in salt-sensitive hypertension. Hypertension 2006;47:557–62
   PubMed Web of Science ®Google Scholar
• Guzik TJ, Hoch NE, Brown KA, et al. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 2007;204:2449–60
   PubMed Web of Science ®Google Scholar
• Elmarakby AA, Quigley JE, Imig JD, et al. TNF-alpha inhibition reduces renal injury in DOCA-salt hypertensive rats. Am J Physiol Regul Integr Comp Physiol 2008;294:R76–83
   PubMedGoogle Scholar
• Sriramula S, Haque M, Majid DS, Francis J. Involvement of tumor necrosis factor-alpha in angiotensin II-mediated effects on salt appetite, hypertension, and cardiac hypertrophy. Hypertension 2008;51:1345–51
   PubMed Web of Science ®Google Scholar
• Venegas-Pont M, Manigrasso MB, Grifoni SC, et al. Tumor necrosis factor-alpha antagonist etanercept decreases blood pressure and protects the kidney in a mouse model of systemic lupus erythematosus. Hypertension 2010;56:643–9
   PubMed Web of Science ®Google Scholar
• Laresgoiti-Servitje E. A leading role for the immune system in the pathophysiology of preeclampsia. J Leukocyte Biol 2013;94:247–57
   PubMed Web of Science ®Google Scholar
• Kupferminc MJ, Peaceman AM, Aderka D, et al. Soluble tumor necrosis factor receptors and interleukin-6 levels in patients with severe preeclampsia. Obstet Gynecol 1996;88:420–7
   PubMed Web of Science ®Google Scholar
• Williams MA, Farrand A, Mittendorf R, et al. Maternal second trimester serum tumor necrosis factor-alpha-soluble receptor p55 (sTNFp55) and subsequent risk of preeclampsia. Am J Epidemiol 1999;149:323–9
   PubMed Web of Science ®Google Scholar
• Schipper EJ, Bolte AC, Schalkwijk CG, et al. TNF-receptor levels in preeclampsia – results of a longitudinal study in high-risk women. J Matern Fetal Neonatal Med 2005;18:283–7
   PubMed Web of Science ®Google Scholar
• Laskowska M, Laskowska K, Leszczynska-Gorzelak B, Oleszczuk J. Maternal and umbilical sTNF-R1 in preeclamptic pregnancies with intrauterine normal and growth retarded fetus. Hypertens Pregnancy 2007;26:13–21
   PubMed Web of Science ®Google Scholar
• Annunziato F, Cosmi L, Liotta F, et al. Phenotype, localization, and mechanism of suppression of CD4(+)CD25(+) human thymocytes. J Exp Med 2002;196:379–87
   PubMed Web of Science ®Google Scholar
• Hijdra D, Vorselaars AD, Grutters JC, et al. Differential expression of TNFR1 (CD120a) and TNFR2 (CD120b) on subpopulations of human monocytes. J Inflamm (Lond) 2012;9:38–43
   PubMed Web of Science ®Google Scholar
• Chen X, Baumel M, Mannel DN, et al. Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells. J Immunol 2007;179:154–61
   PubMed Web of Science ®Google Scholar
• van Mierlo GJ, Scherer HU, Hameetman M, et al. Cutting edge: TNFR-shedding by CD4+CD25+ regulatory T cells inhibits the induction of inflammatory mediators. J Immunol 2008;180:2747–51
   PubMedGoogle Scholar
• Valencia X, Stephens G, Goldbach-Mansky R, et al. TNF downmodulates the function of human CD4+CD25hi T-regulatory cells. Blood 2006;108:253–61
   PubMed Web of Science ®Google Scholar
• Chen X, Subleski JJ, Kopf H, et al. Cutting edge: expression of TNFR2 defines a maximally suppressive subset of mouse CD4+CD25+FoxP3+ T regulatory cells: applicability to tumor-infiltrating T regulatory cells. J Immunol 2008;180:6467–71
   PubMed Web of Science ®Google Scholar
• Chen X, Oppenheim JJ. The phenotypic and functional consequences of tumour necrosis factor receptor type 2 expression on CD4(+) FoxP3(+) regulatory T cells. Immunology 2011;133:426–33
   PubMed Web of Science ®Google Scholar
• Chen CCA, Pedraza PL, Hao S, et al. TNFR1 deficient mice display altered blood pressure and renal responses to Ang II infusion. Am J Physiol Renal Physiol 2010;299:F1141–50
   PubMedGoogle Scholar
• Toldi G, Svec P, Vasarhelyi B, et al. Decreased number of FoxP3+ regulatory T cells in preeclampsia. Acta Obstet Gynecol Scand 2008;87:1229–33
   PubMed Web of Science ®Google Scholar
• Steinborn A, Haensch GM, Mahnke K, et al. Distinct subsets of regulatory T cells during pregnancy: is the imbalance of these subsets involved in the pathogenesis of preeclampsia? Clin Immunol 2008;129:401–12
   PubMed Web of Science ®Google Scholar
• Ding AH, Porteu F, Sanchez E, Nathan CF. Downregulation of tumor necrosis factor receptors on macrophages and endothelial cells by microtubule depolymerizing agents. J Exp Med 1990;171:715–27
   PubMed Web of Science ®Google Scholar
• Watanabe N, Kuriyama H, Sone H, et al. Continuous internalization of tumor necrosis factor receptors in a human myosarcoma cell line. J Biol Chem 1988;263:10262–6
   PubMed Web of Science ®Google Scholar